Medibio Ltd
ASX:MEB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Medibio Ltd
ASX:MEB
|
AU |
|
C
|
Caliway Biopharmaceuticals Co Ltd
TWSE:6919
|
TW |
|
A
|
Ability Enterprise Co Ltd
TWSE:2374
|
TW |
Shareholder Yield
Current shareholder yield for MEB is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Price Appreciation
MEB Price
Medibio Ltd
| Average Annual Return | -40% |
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -92% |
| Market Capitalization | 122m AUD |
| Shares Outstanding | 6 100 743 763 |
| Percentage of Shares Shorted |
N/A
|
MEB Return Decomposition
Main factors of price return
Stock Splits
MEB's latest stock split occurred on Oct 23, 2023
The company executed a 1-for-20 stock split, meaning that for every 20 shares held, investors received 1 new share.
Before the split, MEB traded at 0.02 per share. Afterward, the share price was about 0.02.
The adjusted shares began trading on Oct 23, 2023. This was MEB's 3rd stock split, following the previous one in Mar 10, 2015.
